First published in 1984, this book examines corporate crime in the pharmaceutical industry and is based on extensive research, including interviews with 131 senior executives of international pharmaceutical companies. It covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs.

Preface 1. Introduction: an industry case study of corporate crime 2. Bribery 3. Safety testing of drugs: from negligence to fraud 4. Unsafe manufacturing practices 5. Antitrust 6. The corporation as pusher 7. Drug companies and the Third World 8. Fiddling 9. Strategies for controlling corporate crime; Appendix: Getting interviews with corporate executives; Notes; Bibliography; Index